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GROWTH AND SURVIVAL IN SMALL
HEPATOCELLULAR CARCINOMA
ABSTRACT
Barbara, L., Benzi, G., Gaiani, S., Fusconi, F., Zironi, G., Sirongo, S.,
Rigamonti, A., Barbara, C., Grigioni, W., Mazziotti, A., Bolondi, L. (1992)
Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multi-
variate analysis of prognostic factors of tumour growth rate and patient suroival.
Hepatology; 16: 132-137.
We analyzed the growth pattern of tumor masses and the survival of 39 asymptoma-
tic Italian patients with a total of 59 small (-< 5 cm in diameter) hepatocellular
carcinomas arising from cirrhosis. The total length of the observation period ranged
from 90 to 962 days, with an average of 364 _+ 229 (mean __+ S.D.). Doubling time
ranged from 27.2 to 605.6 days (mean _
S.D., 204.2 _
135; median 171.6 days).
Three different growth patterns were recognized: (a) tumors with no or very slow
initial growth pattern (doubling time > 200 days), 10 cases (37%); (b) tumors with
declining growth rate over time, 9 cases (33.4%); and (c) tumors with almost
constant growth rate, 8 cases (29.6%). Using the stepwise discriminant analysis, we
found a score based on albumin, alcohol intake, number of nodules, echo pattern
and histological type that allowed a correct prediction of short doubling time ( <- 150
days) in 55.6%, medium doubling time (151 to 300 days) in 60% and long doubling
time (> 300 days) in 100% of cases. The estimated survival rate of the 39 patients,HPB INTERNATIONAL 255
calculated by the Kaplan-Meier method was 81% at 1 yr, 55.7% at 2 yr and 21% at
3 yr. Stepwise discriminant analysis showed that a score based on sex, HBsAg status,
alcohol consumption, ascites, 7-glutamyltranspeptidase, prothrombin time,
Child-Pugh class and all the sonographicai parameters could predict 2-yr survival in
100% of cases. We conclude that great variability of growth patterns exists among
and within small hepatocellular carcinomas. Prediction of subsequent growth rate is
unreliable in most cases. The sonographical characteristics, together with the
histological features, can, however, help in identifying cases with long doubling time
(> 300 days). The discriminant analysis on survival of cirrhotic patients with small
hepatocellular carcinomas demonstrates that the underlying liver disease plays a key
role in the long-term survival probability. (Hepatology, 1992; 16:132-137.)
PAPER DISCUSSION
KEY WORDS: Small hepatocellular carcinoma, hepatocellular carcinoma growth
rate
With the recent progress in imaging diagnosis, small space occupying lesions have
come to be detected in the liver1, and ultrasonography can now detect an hepatic
mass smaller than 2 cm2. In the past, diagnosis of hepatocellular carcinoma (HCC)
was possible only in symptomatic patients and the tumor size was invariably larger
than 5 cm on detection. The Japanese gastroenterologists are to be credited for
developing the diagnostic strategy or practice for early detection of HCC, namely,
patients with cirrhosis are followed at a short regular interval with ultrasound
examination and serum alpha-fetoprotein (AFP) measurement3. The same practice
was immediately adopted in Taiwan, and later by the north Italian colleagues,
notably Luigi Bolondi and Massimo Colombo. It is of interest in this connection
that the incidence rate for HCC has been rising both in Italy
4 and Japan5, the
increase being accounted for by chronic hepatitis C virus infection6’7.
When one detects a small HCC in a patient with cirrhosis, what should be done?
Currently, a number of therapeutic modalities for the treatment of HCC are
available, such as hepatic resection, orthotopic liver transplantation, chemother-
apy, arterial embolization, lipiodolization, intratumor ethanol injection, irradia-
tion, immunotherapy, etc. The prognosis of such small HCC depends on the speed
of tumor growth as well as on the severity of cirrhosis. For the selection of
therapeutic modality, therefore, one has to take into consideration the degree and
speed of cirrhotic changes and growth rate of the HCC in each patient; the natural
history of the disease was almost totally unpredictable in the past.
In this study, Barbara, Bolondi and their group in Bologna attempted to
determine how well one can predict the speed of tumor growth and survival from
the clinical and biochemical data at the time of tumor detection. Their study was
based on a retrospective analysis of 39 asymptomatic Italian patients with a total of
59 smallHCC lesions (less than 5 cm) associated with cirrhosis. They followed them
for an average of 364 days while measuring the tumor doubling time (DT) without
giving any specific treatment. They carried out the stepwise discriminant analysis
with the data on albumin, bilirubin, prothrombin time, gamma-glutamyl-
transpeptidase (GGT), HBsAg, ferritin, AFP, excessive alcohol intake, ascites,256 HPB INTERNATIONAL
Child-Pugh class, number of tumor nodules, echo characteristics, tumor boundar-
ies, histological type and Edmondson-Steiner’s grade of differentiation8. They
found that albumin, alcohol, number of nodules, echo pattern and histological type
allowed a correct prediction of very long DT, and that survival at 2 years could also
be predicted from the score calculated from sex, HBsAg, alcohol, ascites, GGT,
prothrombin time, Child-Pugh class and sonographic parameters. It was in 1986
that Ebara et al.
9 first suggested that sonographic charcteristics were correlated with
tumor growth speed, and this study seems to corroborate these observations.
However, they emphasize that prediction of DT is generally difficult, and that the
underlying liver disease plays a key role in the long term survival probability.
Earlier, Calvet et al.1 in Spain carried out a multivariate analysis based on clinical
parameters that included toxic syndrome and metastases in 206 patients, but these
patients were mostly advanced cases. The Spanish study and the current one are
not comparable, and the latter is applicable only to small HCC.
In this study, varying growth rates were grouped into short (less than 150 days),
average (150-300 d) and very long (more than 300 d) DT. However, the growth
rate changed suddenly to a faster or a slower rate in a number of cases; a separate
analysis may be required for such cases. In calculating the risk factor, such variables
as albumin, bilirubin, GGT, AFP and prothrombin time were put into dichotomous
variables; present 1, absent 0. They should have been dichotomized above and
below a certain value, or at least more information is needed for the reader
interested in using the proposed method for assessing the prognosis.
In the discussion, they point out certain differences between north Italian and
Asian patients; tumor grows slower and patients live longer without treatment in
north Italy. Although they comment on differences in the predictive value of AFP
between their study and two reports from Asia11’12, these studies were based on
different sorts of patients and different modes of AFP value analysis, and this
reviewer does not see any basic difference. A one-point value of AFP in a small
HCC itself is of little prognostic value as the authors emphasize, but for more
advanced HCC, AFP at diagnosis may be of prognostic significance12. They failed
to show correlation between severity of cirrhosis and DT; a small HCC found in a
liver with advanced cirrhosis tends to grow slowly in Japan, although this tendency
has not been statistically documented. It is now established that malignant transfor-
mation is a multistep process, and the molecular events that underlie this process
vary with the carcinogenic factors7. It is no surprise that the natural history differs
somewhat between Italy and the Far East. Despite these geographic differences
suggested by this study, their findings are of practical relevance regardless of the
global region for those who are engaged in the diagnosis and treatment of HCC
patients. The study was well planned and executed, and the results provide an
important piece of information on the prognosis of HCC. While realizing that to
detect a small HCC in 39 patients in a European country really requires an
enormous amount of work and time, this reviewer suggests that they reanalyze
these parameters in the future when they have accumulated a greater number of
such patients.
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BUDD-CHIARI SYNDROME: SHUNT OR
TRANSPLANT?
ABSTRACT
Shaked, A., Goldstein, R.M., Klintmalm, G.B., Drazan, K., Husberg, B. and
Busuttil, R.W. (1992) Portosystemic shunt oersus orthotopic lioer transplantationfor
the Budd-Chiari Syndrome. Surgery, Gynecology & Obstetrics; 174: 453-459.
We have analyzed the indications and results of shunt operation versus orthotopic
liver transplantation (OLT) in 22 patients with Budd-Chiari syndrome (BCS). The
underlying cause of the syndrome was similar between the two groups and was
related to myeloproliferative disorders or the use of birth control, pills in 18 of 22
patients. The results of biopsies of the liver showed centrilobular congestion and
necrosis in all candidates who underwent shunting and the presence of fibrosis and
cirrhosis in the OLT candidates. The indications for shunts included symptoms
related to portal hypertension only and well-preserved synthetic hepatic function.
Ten patients were treated with 12 shunt procedures, including mesoatrial (eight
patients) and side to side portacaval shunt (four patients). Significant complications